Philadelphia, PA 19104
United States
University of Pennsylvania - Department of Medicine
COVID-19, SARS-CoV-2, Convalescent plasma, Functional antibodies, Fc modification, antibody glycosylation, antibody therapeutics, nucleocapsid, shifts in immunodominance, immunomodulation, COVID therapeutics